The Single-Lead ECG Monitors Market to thrive on personalization of healthcare experience at a CAGR of 9.9%

Single-Lead ECG Monitors Market 2022

Technologies are driving the healthcare vertical through numerous innovations in the way diseases are diagnosed, prevented, and cured. With AI-driven technologies witnessing excessive incorporation in healthcare workflows, quality medical services are expected to get unleashed in higher proportion in the years to come. AI-based innovations help to foster mental health as well. Diagnostics are also expected to get better going with healthcare technology in the forecast period. This would be the way of operation of healthcare technology going forward.

Get Free Sample Copy Of This Report @  https://www.persistencemarketresearch.com/samples/3784

Understanding various facets of the global single-lead ECG monitors market, Persistence Market Research has come up with an analytical research publication titled “Single-Lead ECG Monitors Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. The comprehensive single-lead ECG monitors market research report focuses on various trends, developments, opportunities, restraints, drivers and challenges impacting the growth of the global single-lead ECG monitors market. These factors vary in magnitude in different regions for which a detailed analysis is covered in this research report. Along with this, a detailed competition assessment and forecasts for a period of eight years from 2017-2025 are elaborated with respect to each segment and sub-segment of the global single-lead ECG monitors market.

Global Single-Lead ECG Monitors Market: Market Forecast Analysis

The global single-lead ECG monitors market is expected to witness stellar growth in the coming years. The global market for single-lead ECG monitors was valued at around US$ 344 Mn in 2017 and is estimated to reach more than US$ 730 Mn by the end of 2025. The global market for single-lead ECG monitors is projected to grow at a value CAGR of 9.9% throughout the period of forecast (2017-2025).

Global Single-Lead ECG Monitors Market: Insights on Market Segments

The global market for single-lead ECG monitors is segmented on the basis of product type, application, end user and region.

  • By product type, recording based single-lead ECG monitor segment is estimated to largely contribute to the of the global market. The real-time single-lead ECG monitor segment is projected to grow at a comparatively high CAGR of 12.9% during the forecast period
  • Application wise, there is a higher demand for single-lead ECG monitors in atrial fibrillation indication. The atrial fibrillation application segment is also estimated to be the largest and expected to be the most lucrative in the coming year
  • By region, use of single-lead ECG monitors in North America, especially in the U.S, is increasing at a high scale due to increasing prevalence of cardiovascular and other chronic diseases. Moreover, Asia Pacific region is expected to show higher adoption of single-lead ECG monitors, thus making this region as a potential growth propeller portraying huge opportunities for manufacturers of single-lead ECG monitors
  • By end user, home care settings segment is expected to show significant market attractiveness with respect to use of single-lead ECGs. However, hospital facilities segment is the largest with a high market US$ 186 Mn in 2017

Global Single-Lead ECG Monitors Market: Underlying Aspects

There are several underlying aspects that have an influence on the growth of the global market for single-lead ECG monitors. Factors such as increasing prevalence of chronic diseases, low cost of low end ECG monitors, increasing technological advancements, increasing preference for portable ECG coupled with low cost of portable ECGs, rising number of patients suffering from cardiovascular diseases, growing number of small players in emerging economies and growing distribution network for ECGs is expected to fuel the growth of the global single-lead ECG monitors market. On the other hand, high demand for high end ECG monitors and 12 lead ECG monitors is expected to curb the demand for single-lead ECG monitors. Other aspects such as lack of awareness about latest technology and limited adoption among general population have a negative impact on the market’s growth.

Request For Customization @   https://www.persistencemarketresearch.com/request-customization/3784

Global Single-Lead ECG Monitors Market: Competition Landscape

The global single-lead ECG monitors market research report has analyzed various key players involved in the manufacturing of single-lead ECGs. Few of these players include DailyCare BioMedical Inc., Shenzhen Creative Industry Co. Ltd., AliveCor Inc., Medtronic Plc., LifeWatch AG, OMRON Healthcare, Lohman Technologies (Cardiac Advancements LLC), iRhythm Technologies Ltd., Reka Health Pte Ltd., Beijing Choice Electronic Tech Co., Ltd (ChoiceMMed), DIMETEK Digital Medical Technologies, Ltd., Cardiac Design Labs, Thermo Fisher Scientific, Inc., Lyfas, Acculi Labs Pvt. Ltd. India,   Vital Connect Inc., Qardio, Inc., ProtoCentral and NUUBO Smart Solutions Technologies, SL.

Key Questions Answered in This Report.

  • What will the Market growth rate in Future?
  • What are the key factors driving the global Market?
  • Who are the key manufacturers in Market space?
  • What are the opportunities and threats faced by the vendors in the global industry?
  • What are sales, revenue, and price analysis by regions of industry?

Get up to 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/3784

About us: –

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Contact Us:

Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Wearable medical devices to dictate growth of the Medical Tapes and Bandages Market at a CAGR of 3.6%

According to the latest report by Persistence Market Research (PMR), the global medical tapes and bandages market is expected to witness sluggish growth. The market is estimated to increase to 3.6% CAGR during the forecast period 2017-2022. It is also expected to reach US$ 7,403.0 million revenue by the end of 2022.

In order to fasten the process of healing the wound, and provide protection from bacteria and environmental factors such as water, air, etc. medical tapes and bandages are being used on a large scale. Manufacturers are focusing on introducing new medical bandages and tapes products such as skin sensitive tapes, anti-bacterial tape and bandages, tapes for sports professionals that can resist the movement for a long time.

Want Insights To Medical Tapes And Bandages Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/20317

Company Profiles

  • Medtronic plc
  • 3M Company
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Smith & Nephew Plc
  • Nitto Denko Corporation
  • Cardinal Health Inc.
  • Beiersdorf Aktiengesellschaft
  • Lohmann & Rauscher International GmbH & Co. KG
  • Paul Hartmann AG
  • Medline Industries Inc.

Planning To Conclude Your Strategy On A Decisive Note In The Medical Tapes And Bandages Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/20317

Factors including the rise in aging population, increasing number of accidents, the rise in a number of surgeries being conducted and the growth in the knowledge of taking proper care of wounds are contributing to the market growth.

Emergence of Advanced Wound Care Products to Hamper the Growth of Medical Tapes and Bandages Market

Increasing use of the advanced wound care products is hampering the global medical tapes and bandages market. Proper wound management as per the condition of the patient and type of wound is also being focused on.

Hence, to provide the right treatment for wounds, medical professionals are using advanced wound care products that can be applied in the early stage of treatment, resulting in the quick healing and reduced risk of infection. Various types of wounds include traumatic, surgical, arterial, diabetic, pressure, and venous.

Hence, treating different types of wounds require various types of wound care product as per the wound.

Advanced wound care products facilitating fast wound healing are being produced by manufacturers which can be used for both primary and secondary dressing. For example, foams, alginates, hydrocolloids, hydrogels, etc. Advanced wound care products are also being developed that can maintain a stable temperature around the wound, provide oxygen flow, relieves pain, and removes dead tissue and prevents scarring.

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/20317

Global Medical Tapes and Bandages Market: Segmental Insights

The global medical tapes and bandages market is segmented on the basis of end user, product type and application. Based on the product type, medical bandages are expected to witness growth in the global medical tapes and bandages market. By the end of 2022, medical bandages are estimated to reach nearly US$ 5,900 million revenue.

By end user, market segmentation includes hospitals, clinics, home care settings and ambulatory surgery centers. Among these, Hospitals are expected to dominate the global medical tapes and bandages market. By the end of 2017, hospitals are estimated to account for more than half of the revenue share.

Based on the application, surgical wound treatments are expected to emerge as the largest segment in terms of application. Surgical wound treatment is estimated to exceed US$ 3,100 million revenue by the end of 2022.

Geographically, the global medical tapes and bandages market is categorized into Europe, North America, Asia Pacific Excluding Japan (APEJ), Latin America, Japan, and the Middle East and Africa (MEA). Among these, North America is expected to dominate the global medical tapes and bandages market. North America is estimated to exceed US$ 2,200 million revenue by the end of 2022.

Prevalence of chronic wounds, orthopedic injuries and rise in the surgeries are resulting in the increasing use of bandages and medical tapes in the region. Meanwhile, APEJ and Europe are also expected to witness growth during the forecast period 2017-2026.

About us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

The Herpes Marker Testing Market to witness virtual-reality simulations at a CAGR of 6.1%

Herpes Markers Testing Market 2022

The global market is expected to be valued at US$ 481.8 Mn by 2025 and expand at a CAGR of 6.1% over the forecast period (2017–2025). The overall market is anticipated to grow 1.7x in terms of value over the forecast period. According to the latest market report published by Persistence Market Research titled ‘Herpes Marker Testing Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025)’

Request for Free Sample Copy of Herpes Markers Testing Market Report@https://www.persistencemarketresearch.com/samples/4185

Market Dynamics

Certain factors such as positive diagnostic lab industry dynamics, increasing herpes prevalence, rising awareness, support from various government and non-government organizations, new product approvals and launches, increasing focus on evidence based medicines etc. are boosting revenue growth of the market. However, insufficient R&D initiatives, poor access to diagnostic services in remote areas, pricing pressures, and stringent regulations are some of the factors restricting growth of the market.

Key Companies-

  • Abbott Laboratories
  • Abcam Plc
  • BioMérieux SA
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • DiaSorin S.p.A.
  • Quidel Corporation
  • Luminex Corporation
  • Merck KGaA
  • Qiagen N.V.
  • Norgen Biotek Corp.
  • Hologic Inc.
  • Bio Rad Laboratories Inc.
  • Meridian Bioscience Inc.
  • Teco Diagnostics
  • Others.

Herpes Marker Testing Market

Request For Customization@https://www.persistencemarketresearch.com/request-customization/4185

Segmental Forecast

  • On the basis of test type, the market has been segmented into viral culture test, nucleic acid amplification-based kits and antibody/antigen-based kits. Antibody/Antigen based kits is the highest revenue generating segment over the forecast period owing to the huge product availability as well as high physician preference for this test type. Nucleic Acid Amplification-based kits segment will report the highest growth rate over the forecast period due to the growing acceptance of PCR diagnosis as a gold standard test in herpes testing owing to high sensitivity, specificity and positivity ratio for herpes diagnosis. Antibody/Antigen based kits is projected to be the most attractive segment with an attractiveness index of 1.5 during the forecast period.
  • Based on the indication, the market has been segmented into HSV-1, HSV-2 and HSV-1/ HSV-2. HSV-1/HSV-2 segment dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. HSV-1/HSV-2 is projected to be the most attractive segment with an attractiveness index of 1.6 and growth rate of 6.5% during the forecast period.
  • On the basis of application, the market has been segmented into research use and clinical diagnostics segment. Clinical diagnostics application dominates the market for herpes marker testing with a value share in excess of 85% throughout the forecast period.
  • Based on end user, the market has been segmented into hospitals, diagnostics centers, clinics and academic & research institutes. Among all the end users, most of the revenue is generated via the diagnostic centers sales followed by hospitals owing to the maximum number of tests being performed at these facilities. Diagnostics centers dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. This segment represents a market attractiveness index of 1.6 over the forecast period.
  • Among the regional markets, North America holds the maximum value share in the global market owing to the accessibility and affordability of diagnostic services in the region and a favorable reimbursement scenario. In terms of growth rate, North America leads with a CAGR of 6.4% followed by Asia Pacific with a CAGR of 6.3%. Asia Pacific represents a highly potential market with a significant growth rate owing to the increasing awareness as well as increasing penetration of market players in the region. The market in Europe ranks third in terms of global market size as well as growth rate while Latin America represents the least market attractiveness index over the forecast period.

Get up to 20% off on Immediate Purchase @  https://www.persistencemarketresearch.com/checkout/4185

Key Questions Answered in This Report-

  • What will the Market growth rate in Future?
  • What are the key factors driving the global Market?
  • Who are the key manufacturers in Market space?
  • What are the opportunities and threats faced by the vendors in the global industry?
  • What are sales, revenue, and price analysis by regions of industry?

 

About us: –

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Contact Us:

Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Preventive care to be the centrepoint of the Biosimulation Market at a CAGR of 11.5%

Biosimulation Market

In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discovery and development of new drugs, in the area of drug metabolism and in the modeling of biomedical systems that are complex.

There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure at a later stage in the development of new drugs is too high. In order to counter such problems, biosimulation is used as a predictive tool and it helps in the prediction of the future outcomes of the drug development by simulation of the biological processes involved.

Get Going With Sample Of Biosimulation Market Report! https://www.persistencemarketresearch.com/samples/3726

Company Profiles

  • Certara, L.P
  • Simulations Plus, Inc..
  • Dassault Systemes SE
  • Schrodinger, Inc
  • Advanced Chemistry Development, Inc.
  • Entelos, Inc.
  • Evidera, Inc.
  • Genedata AG
  • Leadscope Inc
  • Acceryls Inc.

How About Re-Inventing The Methodical Wheel In The Biosimulation Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.com/methodology/3726

This is the main factor supporting the growth of the global biosimulation market. However, high costs associated with the R&D related to biosimulation and a lack of qualified workforce are the main restraints hampering the growth of this market.

The global biosimulation market is slated to touch a value of about US$ 1,750 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

4 Forecast Highlights on Global Biosimulation Market

As per the forecast of Persistence Market Research, the services product type segment is slated to touch a value of nearly US$ 700 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The services product type segment is estimated to account for more than one-third of the revenue share of the product segment by the year 2017 and is forecasted to gain market share by 2022 over 2017.

As per the forecast of Persistence Market Research, the pharmaceutical and biotech companies segment will reach a value of about US$ 350 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The pharmaceutical and biotech companies segment is forecasted to account for more than one-third of the total revenue share of the end user segment by the end of the year 2017 and is expected to lose in market share by 2022 as compared with the year 2017.

As per the forecast of Persistence Market Research, the drug development segment is slated to reach a value of nearly US$ 1,000 Mn in 2022. The drug development segment is expected to gain market share by the end of the year 2022. The largest share is contributed by the North America region in the drug development segment.

Persistence Market Research forecasts the U.S. biosimulation market to exhibit a compound annual growth rate (CAGR) of more than 13% from 2017 to 2022.

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/3726

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

The Examination Tables Market to foray into digital innovation, witnessing a CAGR of 4.0%

With a growing load on the healthcare sector and consequently on the healthcare practitioners, the hospitals are looking for ways constantly to improve the working conditions of the doctors, nurses and other treatment staff. Hence, in order to avoid problems like back pain in doctors and nurses, ergonomically designed patient examination tables are used that are safe, flexible and reliable.

Examination tables are used to give support to the patients during a medical examination. Examination tables are equipped with a hydraulic device or an electric motor so that the table can transform from a fully reclined position to a straight seated position so that to facilitate the examination of the patient by the doctor.

Want Insights To Examination Tables Market? Ask For Sample! https://www.persistencemarketresearch.com/samples/18583

Company Profiles

  • Cardinal Health, Inc.
  • Allengers Medical Systems Limited
  • Narang Medical Limited
  • Skytron Corporation
  • United Metal Fabricators, Inc
  • ADDvise Group AB
  • Hamilton Medical AG

Planning To Conclude Your Strategy On A Decisive Note In The Examination Tables Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.com/methodology/18583

Rise in the number of chronic diseases, rise in the number of old age patients and increasing healthcare spending are some of the major factors contributing to the progress of the examination tables market.

The global examination tables market is slated to touch a value of about US$ 440 Mn in the year 2022 and display a moderate CAGR during the assessment period.

4 Forecast Highlights on Global Examination Tables Market

As per the forecast of Persistence Market Research, the special examination table segment is slated to touch a value of nearly US$ 150 Mn in the year 2022. This represents a moderate CAGR during the assessment period of 2017-2022. The special examination table segment is estimated to account for nearly one-third of the revenue share of the product type segment by the year 2017 and is forecasted to gain market share by 2022 over 2017.

Get up to 20% off on Immediate Purchase @ https://www.persistencemarketresearch.com/checkout/18583

As per the forecast of Persistence Market Research, the ASCs end user segment will reach a value of nearly US$ 100 Mn in the year 2017. This represents a moderate CAGR growth during the forecast period. The ASCs end user segment is forecasted to account for more than one-fourth of the total revenue share of the end user segment by the end of the year 2017 and is expected to gain in market share by 2022 as compared with the year 2017.

As per the forecast of Persistence Market Research, the powered source type segment is slated to reach a value of about US$ 140 Mn in 2022. The powered source type segment is expected to lose market share by the end of the year 2022. The largest share is contributed by the Europe region in the strips powered source type segment.

Persistence Market Research forecasts the Germany examination tables market to exhibit a compound annual growth rate (CAGR) of less than 5.0% from 2017 to 2022.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

The Hip Replacement Market to grow on the back of on-demand healthcare, witnessing a CAGR of 2.7%

Understanding various aspects of the hip resurfacing implants market, Persistence Market Research has put forth an in-depth research analysis on the global market for hip resurfacing implants in a cohesive manner in its latest publication titled Hip Resurfacing Implants Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”.

There are several factors that have impacted the growth of the global hip resurfacing implants market and the intensity of these factors changes from region to region. In this analytical research study, numerous developments, trends, drivers, restraints and opportunities have been assessed across key regions of North America, Latin America, Europe, Asia Pacific (APAC) and Middle East and Africa (MEA).

Planning Forward? Access Sample Of Hip Resurfacing Implants Market Report! https://www.persistencemarketresearch.co/samples/5438

Company Profiles 

  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew
  • MicroPort Scientific Corporation
  • Corin Group Plc
  • BioPro
  • Implantcast GmBH
  • MatOrtho Limited

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Hip Resurfacing Implants Market? https://www.persistencemarketresearch.co/methodology/5438

This research study portrays an all-inclusive market scenario of hip resurfacing implants that includes analysis on major segments of the market thus covering every angle to present a realistic market scenario. Additionally, the research report delivers value to the reader by including future market projections based on historical data and current market scenario.

Global Hip Resurfacing Implants Market: Forecast Highlights

According to the research report, the global hip resurfacing implants market is expected to grow at a slow pace during the period of assessment. The global market is valued at around US$ 160 Mn in 2017 and is estimated to reach about US$ 195 Mn by the end of the period of forecast (2025). The global hip resurfacing implants market is projected to grow at a sluggish CAGR of 2.7% throughout the period of forecast, 2017-2025.

Global Hip Resurfacing Implants Market: Key Growth Influencing Factors

Various aspects have impacted the growth of the global market for hip resurfacing implants. Factors such as rising demand for metal-on-metal resurfacing implants, increasing advancements to facilitate outpatient settings owing to which outpatient hip arthroplasty has gained momentum, low cost of hip resurfacing in underdeveloped regions, rising acceptance of minimally invasive hip replacements, increasing technological advancements and emergence of robot assisted surgeries have contributed to the growth of the global hip resurfacing implants market.

However, recall of implants used in hip resurfacing, lack of awareness about hip resurfacing implants, growing failure rates leading to reduction in hip resurfacing volumes in several regions and metal ion risk in metal-on-metal implants used in hip resurfacing ultimately leading to the failure of the implant are posing hindrances to the growth of the global hip resurfacing implants market.

Global Hip Resurfacing Implants Market: Segmental Insights

The global resurfacing implants market has been segmented by material type, by end user and by region.

By region, North America region is expected to show high market attractiveness for hip resurfacing implants. The hip resurfacing implants market in North America is expected to reach a value of about US$ 100 Mn by the end of the forecast period and is the largest compared to other regions. Asia Pacific hip resurfacing implants market is projected to grow at the highest rate to reach a CAGR of 3.1% throughout the period of forecast

By end user, hospitals is the most lucrative segment in the coming years. It is expected to grow at the highest CAGR to reach a significant about US$ 110 Mn by the end of 2025

By material type, hybrid alloy segment witnessed a high market share and is estimated to reflect a high US$ 100 Mn by the end of the assessment year

Get up to 20% off on Immediate Purchase @ https://www.persistencemarketresearch.com/checkout/5438

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Adoption of digital strategies by the healthcare vertical to be the cornerstone of Polycystic Ovarian Syndrome Drugs Market at a CAGR of 3.9%

According to the latest market report published by Persistence Market Research titled ‘Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers and trends likely to impact the market during the forecast period.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3682

Company Profiles:

  • Sanofi
  • Novartis AG
  • Teva Pharmaceutical Industries Limited
  • Addex Therapeutics Ltd.
  • BIOCAD
  • Merck KGaA
  • AstraZeneca plc.
  • Bristol Myers Squibb Co.
  • Ferring Pharmaceuticals, Inc.
  • Crinetics Pharmaceuticals, Inc.
  • Others

polycystic-ovarian-syndrome-drugs-market-market-bytes

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3682

Growth of the global polycystic ovary syndrome drugs market is mainly driven by increasing prevalence of the disease and a growing awareness among the patient population. Increasing purchasing power among people and rising awareness of PCOS are factors expected to drive growth of the global PCOS drugs market.

The need for effective management of diseases associated with PCOS such as hirsutism, obesity, and infertility is likely to boost the demand for PCOS drugs. Also, a growing popularity of combination drugs and their rising adoption among the patient population is expected to boost revenue growth of the PCOS drugs market in the coming years.

A rising expenditure on research and development activities and introduction of novel drugs is further expected to boost growth of the global polycystic ovary syndrome drugs market over the forecast period. However, lack of FDA approved drugs, a low level of awareness of PCOS in underdeveloped countries, and increasing side effects associated with generics might hamper market growth during the forecast period.

The global market for PCOS drugs presents several growth opportunities for market players. There is a good growth potential in emerging markets and pharmaceutical drugs manufacturers are focusing on emerging economies in the Asia Pacific and Africa such as Kenya, Nigeria, etc. to target a large patient population. Also, effective reimbursement policies and reduction in the costs of drugs used for the treatment of PCOS is likely to increase the adoption of PCOS drugs across the globe.

Leading market players are also investing significantly in developing new branded drugs to treat PCOS, owing to an anticipated high rise in the global patient population. The demand for branded PCOS drugs is likely to increase significantly during the forecast period.

The global PCOS drugs market is segmented based on Drug Class into Oral Contraceptives, Insulin Sensitizing Agents, Anti-Depressants, Ornithine Decarboxylase Inhibitors, Aromatase Inhibitors, and Diuretics. The contraceptive drug class segment is projected to register a CAGR of 5.4% over the forecast period.

Oral contraceptives are generally the preferred first line therapy for the treatment of PCOS as they are easily available as OTC drugs. The insulin sensitizing agent segment is expected to register a CAGR of 4.8% over the forecast period. About 70% of PCOS patients are overweight and are in the category of possible candidates for type 2 diabetes.

Get up to 20% off on Immediate Purchase @ https://www.persistencemarketresearch.com/checkout/3682  

As a result, insulin sensitizing agents are the widely prescribed drugs for the treatment of PCOS today. In terms of value, the oral contraceptives and insulin sensitizing agents drug class segments are collectively expected to remain the dominant and most attractive segments over the forecast period.

The global PCOS drugs market is segmented based on Distribution Channel into Hospital Pharmacies, Drug Stores/OTC, E-Commerce, and Fertility Clinics. The hospital pharmacies segment is likely to lead the global PCOS drugs market in terms of revenue growth and is estimated to be valued at US$ 575.4 Mn by the end of 2024. In terms of value, the drugs stores/OTC segment is estimated to account for 27.0% share of the overall market by the end of 2016.

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and the MEA. The North America market is expected to emerge as the dominant market for polycystic ovary syndrome drugs owing to a high diagnosis rate and increasing adoption of prescription drugs.

North America is estimated to dominate the PCOS drugs market with maximum value share of the overall market by the end of 2016. The presence of well-established pharmaceutical companies in North America as well as a relatively high instance of patients being diagnosed in hospitals for PCOS is a major driver for market growth.

The market in the Asia Pacific region is expected to register the highest CAGR of 5.5% over the forecast period. Significant increase in healthcare services spending along with rapid economic growth and increasing awareness about health issues are some of the key factors likely to push the sales of PCOS drugs in the APAC market.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

The Tissue Processing System Market to enter the arena of digitized nostalgia at a CAGR of 5.7%

Tissue Processing System Market 2022

The research report reflects future market projections of the global tissue processing systems market. The global market for tissue processing systems is expected to reach a value of around US$ 440 Mn by 2025 end from a value of US$ 283.5 Mn in 2017. The global market is projected to grow at a high CAGR of 5.7% during the assessment period.

Persistence Market Research has come up with a fact based analytical research study describing various aspects of the tissue processing systems market across the globe. The analysis on tissue processing systems has been systematically drafted in a new research publication titled “Tissue Processing Systems Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”.

Request for Free Sample Copy of Tissue Processing System Market Report@https://www.persistencemarketresearch.com/samples/14455

This comprehensive research report focuses on various developments, trends, restraints, opportunities, drivers and challenges impacting revenue growth of the global tissue processing systems market. These factors vary in magnitude across different regions for which a detailed analysis is covered in this research report. Along with this, an elaborate competition assessment and forecasts for a period of eight years from 2017-2025 is also presented with respect to each segment and sub-segment of the global tissue processing systems market.

Key Companies-

  • Leica Biosystems Nussloch GmbH
  • Thermo Fisher Scientific Inc.
  • Sakura Finetek Europe B.V.
  • Slee medical GmbH
  • Milestone Srl
  • General Data Company Inc.
  • Agar Scientific Ltd.
  • MEDITE GmbH
  • Bio-Optica Milano SpA
  • Jokoh Co. Ltd.
  • Others.

tissue processing systems market

Request For Customization@https://www.persistencemarketresearch.com/request-customization/14455

Global Tissue Processing Systems Market: Segmentation Assessment

The global tissue processing systems market is segmented by product type, by technology, by end user, by modality and by region.

  • By region, North America is the largest region and reflects high market attractiveness. The tissue processing systems market in the Asia Pacific region is also expected to grow at a higher rate to register a CAGR of 7.3% during the period of assessment
  • By product type, rapid high volume tissue processors is the fastest growing segment and is poised to reflect a CAGR of 7.0% during the period of forecast. The small volume tissue processors segment is the largest segment with a high market share
  • By modality, stand-alone segment is expected to exhibit high lucrativeness in terms of both market value and growth rate in the coming years. This segment is projected to register a CAGR of 6.6% throughout the period of forecast
  • By technology, vacuum tissue processor segment is expected to dominate the global market during the assessment period and is estimated to reach a value little under US$ 320 Mn by 2025 end
  • By end use, diagnostic laboratories have shown higher inclination in the usage of tissue processing systems. The diagnostic laboratories segment is expected to reach a market value of around US$ 225 Mn by the end of the assessment year

Get up to 20% off on Immediate Purchase @  https://www.persistencemarketresearch.com/checkout/14455

Global Tissue Processing Systems Market: Aspects Impacting Growth

Increase in healthcare expenditure, rise in the incidence rate of lifestyle diseases, increase in geriatric population, consolidation of pathology laboratory instruments with one vendor, shortage of pathologists across the globe, rise in prevalence of cancer, increasing focus on emerging and under developed markets, advancements in technology, rising adoption of tissue processing systems in labs to enhance efficiency and expanding access to advanced tissue processors are driving the growth of the global tissue processing systems market. Factors such as high cost of automated tissue processing systems in developed regions and increase in the adoption of refurbished tissue processing systems are anticipated to pose restraints to the growth of the global tissue processing systems market.

About us: –

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Contact Us:

Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

The Next Generation Iv Infusion Pumps Market to revolve around competitive health goals at a CAGR of 5.8%

Improved patient safety, efficient dose administration, and seamless interoperability for advanced infusion delivery are several advantages offered by next-generation IV infusion pumps. Novel utilization in existing treatments and promising discovery of innovation pumps have led to the expansion of the next-generation IV infusion pumps market.

These developments improve patient outcome as well as offer clinicians with patient-specific data to take better informed decisions. Moreover, the rising trend of wireless infusion pumps and wider scope of application in home care settings are factors that are expected to drive market growth further.

How About Looking Through The Sample Of Next Generation Iv Infusion Pumps Market Report? https://www.persistencemarketresearch.com/samples/15781

Company Profiles

  • Becton, Dickinson and Company (CareFusion)
  • Baxter International Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Smiths Medical (Smiths Group plc.)
  • ICU Medical (Hospira Inc.)
  • iRadimed Corporation
  • Zyno Medical
  • Medtronic Plc
  • Terumo Corporation
  • Nipro Corporation
  • Summit Medical Products, Inc
  • Ambu A/S
  • Gamastech S.R.L
  • vTitan
  • Acromed AG
  • Flowonix Medical, Inc
  • Halyard Health
  • Tricumed Medizintechnik GmbH
  • Ivenix, Inc

How About Step-By-Step Insights To Next Generation Iv Infusion Pumps Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.com/methodology/15781

The global next-generation IV infusion pumps market was valued at over US$ 4 Bn in 2018, and is expected to exhibit a CAGR of 6% during the forecast period (2019–2029).

Key Takeaways of Next-Generation IV Infusion Pumps Market Study

By product, large volumetric infusion systems hold around 60% revenue share in the next-generation IV infusion pumps market.

Large volumetric infusion pumps are designed to overcome issues such as size of fluid drops, and are capable of delivering continuous and controlled flow of intravenous fluids, blood products, and whole blood with high level of accuracy.

By application, the pain management segment contributes a significant share to the next-generation IV infusion pumps market, owing to the availability of smart infusion pumps specially designed for different pain management solutions.

Get up to 20% off on Immediate Purchase @  https://www.persistencemarketresearch.com/checkout/15781

Attributed to the in-built safety feature for controlled, small, and constant flow of pain medication, the demand for patient-controlled analgesic pumps (PCA) is expected to increase during the forecast period.

Increasing volume of surgeries performed, rising prevalence of cancer and diabetes, and launch of technologically-advanced products have contributed to the dominance of North America in the global next-generation IV infusion pumps market.

Consistent advancements and technological developments in next-generation IV infusion pumps are the go-to strategies to gain a competitive advantage. Engineers are investigating numerous innovative solutions to design simplified infusion delivery systems for reduction in potential medication errors”, says a PMR Analyst.

New Product Launches Strategic Focus of Next-Generation IV Infusion Pumps Manufacturers

Continuous upgradation and innovation in next-generation IV infusion pumps are responsible for intense competition among market players. Numerous organizations are focusing on new product approvals for next-generation IV infusion pumps.

For example, in June 2019, Ivenix earned FDA clearance for an infusion system designed to make infusion safer and reduce recurring problems associated with infusion pumps. Also, in August 2018, Baxter received CE marking for the Evo IQ infusion system for marketing of the device in the United Kingdom, New Zealand, and Ireland. These winning strategies by leading players are also being followed by regional and local players.

More Valuable Insights on Next-Generation IV Infusion Pumps Market

Persistence Market Research brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2029. 

The global next-generation IV infusion pumps market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader

The study provide compelling insights on the next-generation IV infusion pumps market on the basis of product (large volumetric infusion systems, syringe infusion systems, electronic-ambulatory infusion systems, patient controlled analgesia pumps, disposable elastomeric infusion systems, implantable infusion systems, MRI-compatible IV infusion systems, IV disposables), application (pain management, chemotherapy, clinical nutrition, antibiotic management, others), and end user (hospitals, ambulatory surgical centers, homecare settings, diagnostic centers, others), across five major regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

The Oncology Mice Models Market to thrive on personalization of healthcare experience at a CAGR of 6.0%

Cancer immunotherapy, also known as immuno-oncology, is a type of cancer treatment that utilizes the immune system’s ability to inhibit, control, and eliminate cancer. Immunotherapy educates the immune system to recognize and attack specific cancer cells. Immunotherapy also boosts the immune cells by providing additional components to a body to help them eliminate cancer.

In a recent study by Persistence Market Research on the global oncology mice models market, it was found that the market is set to grow from US$ 390.3 Mn in 2022 to US$ 696.4 Mn by the end of 2032, witnessing high growth during the forecast period. This reflects a CAGR of around 6% over the forecast period (2022-2032).

Despite continuous improvement and identification of novel cancer immunotherapy, there is a pressing need to establish a robust platform to evaluate the efficacy and safety of pre-clinical drugs, simulate the interaction between patients’ tumor and immune systems, and predict patients’ responses to the treatment. Immuno-oncology therapies work by taking breaks off the immune system or boosting its ability to detect and destroy tumor cells.

Most pharma companies are focusing on the production of next-generation combination IO therapies. In recent years, a large number of immuno-oncology drugs were developed by various pharma companies, which can boost the growth of this market.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/33046  

Surge in research of oncology drugs in the past decade has resulted in the generation of a large number of target molecules that need to undergo preclinical and clinical trials for approval. This will help to boost the growth of the market.

  • In September 2021, Harbour BioMed announced IND approval for phase II trial of Anti-FcRn Batoclimab in chronic inflammatory demyelinating polyneuropathy, in China.

Company Profiles:

  • The Jackson Laboratory
  • Taconic Biosciences
  • Charles River Laboratories
  • Shanghai Model Organisms Center Inc.
  • Envigo
  • Biocytogen
  • Genoway
  • Crown Bioscience Inc. (JSR Corporation).
  • Cyagen
  • Applied stem cells
  • Ingenious Targeting Laboratory
  • PolyGene – Transgenic mice model company
  • Creative Biolabs
  • TransCure Bioservices
  • Champions Oncology Inc
  • Certis Oncology
  • Signature
  • Pharmaron
  • Laboratory Corporation of America Holdings
  • Gempharmatech
  • Janvier Labs
  • Harbour BioMed

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/33046

oncology-mice-models-market

Key Takeaways from Market Study

  • Syngeneic tumor mice models contributed the highest revenue share of 56.2% in 2021 in the global market.
  • The end user segment was dominated by contract research organizations with nearly 1/3 revenue share in 2021.
  • North America led the global market with nearly 48.6% value share in 2021.

“The global oncology mice models market is expected to witness significant growth due to development of immuno-oncology combination drugs therapy,” says a Persistence Market Research analyst.

Market Competition

Some of the leading suppliers of mice models are The Jackson Laboratory, Charles River, Taconic Biosciences, Shanghai Model organism, and Envigo amongst others. Key market players are focusing on acquisitions, collaborations, and product launches to increase their revenues across geographies.

  • In February 2021, Charles River acquired Cognate Bioservices to expand its cell and gene therapy programs.
  • In January 2022, Taconic Biosciences announced the launch of the huNOG-EXL EA (Early Access) humanized immune system (HIS) mouse.
  • In October 2021, The Jackson Laboratory announced the acquisition of Charles River Laboratories Japan.
  • In September 2021, Envigo announced a collaboration with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse model.

Get up to 20% off on Immediate Purchase @  https://www.persistencemarketresearch.com/checkout/33046

Want More insights?

Persistence Market Research offers a unique perspective and actionable insights on the global oncology mice models market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on product (humanized immune system mice models, syngeneic tumor mice models, immunodeficient mice models, NOG mice models, spontaneous tumor mice models, and others) and end user (contract research organizations, pharma and biopharma companies, and academic & research institutes), across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa)

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com